US Stock MarketDetailed Quotes

Northwest Biotherapeutics (NWBO)

Watchlist
  • 0.2640
  • +0.0125+4.97%
15min DelayClose May 13 15:58 ET
424.21MMarket Cap-6.60P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Northwest Biotherapeutics (NWBO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-0.29%1.38M
190.91%672K
-43.98%200K
-74.31%131K
32.04%375K
-28.47%1.38M
-48.09%231K
-12.07%357K
153.73%510K
-67.73%284K
Operating revenue
-0.29%1.38M
190.91%672K
-43.98%200K
-74.31%131K
32.04%375K
-28.47%1.38M
-48.09%231K
-12.07%357K
153.73%510K
-67.73%284K
Cost of revenue
Gross profit
Operating expense
-9.72%61.29M
-24.31%14.18M
-4.21%14.52M
-17.05%14.91M
10.34%17.69M
18.19%67.89M
20.16%18.73M
6.51%15.16M
30.45%17.97M
15.78%16.03M
Selling and administrative expenses
-1.50%32.51M
5.06%8.62M
0.60%7.07M
-22.74%7.48M
15.45%9.34M
11.08%33M
0.91%8.21M
-0.03%7.03M
27.99%9.68M
15.80%8.09M
-General and administrative expense
-1.50%32.51M
5.06%8.62M
0.60%7.07M
-22.74%7.48M
15.45%9.34M
11.08%33M
0.91%8.21M
-0.03%7.03M
27.99%9.68M
15.80%8.09M
Research and development costs
-17.49%28.79M
-47.22%5.55M
-8.36%7.45M
-10.41%7.43M
5.15%8.35M
25.81%34.89M
41.17%10.52M
12.90%8.13M
33.46%8.29M
15.76%7.94M
Operating profit
9.91%-59.91M
27.00%-13.5M
3.25%-14.32M
15.37%-14.78M
-9.95%-17.31M
-19.82%-66.51M
-22.17%-18.5M
-7.06%-14.8M
-28.63%-17.46M
-21.44%-15.74M
Net non-operating interest income expense
-11.95%-8.7M
-6.35%-2.65M
-26.01%-2.62M
-8.63%-1.83M
-5.53%-1.6M
-48.20%-7.77M
-100.32%-2.49M
-24.55%-2.08M
-29.11%-1.68M
-47.81%-1.52M
Non-operating interest expense
11.95%8.7M
6.35%2.65M
26.01%2.62M
8.63%1.83M
5.53%1.6M
48.20%7.77M
100.32%2.49M
24.55%2.08M
29.11%1.68M
47.81%1.52M
Other net income (expense)
183.24%7.91M
334.95%17M
-296.63%-9.89M
-3.84%1.23M
59.05%-430K
-413.68%-9.5M
-400.62%-7.24M
68.94%-2.49M
196.06%1.28M
-131.45%-1.05M
Gain on sale of security
432.44%30.4M
1,204.30%21.3M
-198.75%-4.27M
218.23%6.76M
460.31%6.88M
57.23%5.71M
-145.50%-1.93M
169.13%4.33M
164.05%2.12M
-74.43%1.23M
Special income (charges)
-20.87%-17.4M
64.46%-1.6M
41.29%-4M
-394.09%-4.52M
-235.42%-7.28M
-166.39%-14.39M
-155.73%-4.49M
-285.75%-6.82M
-93.64%-914K
-54.19%-2.17M
-Less:Other special charges
20.87%17.4M
-64.46%1.6M
-41.29%4M
394.09%4.52M
235.42%7.28M
166.39%14.39M
155.73%4.49M
285.75%6.82M
93.64%914K
54.19%2.17M
Other non- operating income (expenses)
-521.49%-5.09M
---2.71M
---1.61M
-1,611.94%-1.01M
78.30%-23K
-950.00%-819K
----
----
-32.32%67K
-103.85%-106K
Income before tax
27.55%-60.7M
103.02%851K
-38.48%-26.83M
13.94%-15.38M
-5.63%-19.34M
-33.83%-83.78M
-101.92%-28.22M
17.63%-19.37M
-23.68%-17.87M
-71.91%-18.31M
Income tax
-537K
0
Net income
28.19%-60.16M
104.92%1.39M
-38.48%-26.83M
13.94%-15.38M
-5.63%-19.34M
-33.83%-83.78M
-101.92%-28.22M
17.63%-19.37M
-23.68%-17.87M
-71.91%-18.31M
Net income continuous Operations
28.19%-60.16M
104.92%1.39M
-38.48%-26.83M
13.94%-15.38M
-5.63%-19.34M
-33.83%-83.78M
-101.92%-28.22M
17.63%-19.37M
-23.68%-17.87M
-71.91%-18.31M
Minority interest income
Net income attributable to the parent company
28.19%-60.16M
104.92%1.39M
-38.48%-26.83M
13.94%-15.38M
-5.63%-19.34M
-33.83%-83.78M
-101.92%-28.22M
17.63%-19.37M
-23.68%-17.87M
-71.91%-18.31M
Preferred stock dividends
Other preferred stock dividends
-7.00%1.32M
-49.82%137K
167.42%353K
26.98%560K
-53.35%265K
-20.29%1.41M
-19.94%273K
-74.57%132K
-15.03%441K
43.80%568K
Net income attributable to common stockholders
27.84%-61.48M
104.39%1.25M
-39.35%-27.18M
12.95%-15.94M
-3.86%-19.61M
-32.34%-85.19M
-99.02%-28.5M
18.86%-19.51M
-22.34%-18.31M
-70.91%-18.88M
Basic earnings per share
42.86%-0.04
0
0.00%-0.02
50.00%-0.01
50.00%-0.01
-16.67%-0.07
-100.00%-0.02
0.00%-0.02
-100.00%-0.02
-100.00%-0.02
Diluted earnings per share
42.86%-0.04
0
0.00%-0.02
50.00%-0.01
50.00%-0.01
-16.67%-0.07
-100.00%-0.02
0.00%-0.02
-100.00%-0.02
-100.00%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -0.29%1.38M190.91%672K-43.98%200K-74.31%131K32.04%375K-28.47%1.38M-48.09%231K-12.07%357K153.73%510K-67.73%284K
Operating revenue -0.29%1.38M190.91%672K-43.98%200K-74.31%131K32.04%375K-28.47%1.38M-48.09%231K-12.07%357K153.73%510K-67.73%284K
Cost of revenue
Gross profit
Operating expense -9.72%61.29M-24.31%14.18M-4.21%14.52M-17.05%14.91M10.34%17.69M18.19%67.89M20.16%18.73M6.51%15.16M30.45%17.97M15.78%16.03M
Selling and administrative expenses -1.50%32.51M5.06%8.62M0.60%7.07M-22.74%7.48M15.45%9.34M11.08%33M0.91%8.21M-0.03%7.03M27.99%9.68M15.80%8.09M
-General and administrative expense -1.50%32.51M5.06%8.62M0.60%7.07M-22.74%7.48M15.45%9.34M11.08%33M0.91%8.21M-0.03%7.03M27.99%9.68M15.80%8.09M
Research and development costs -17.49%28.79M-47.22%5.55M-8.36%7.45M-10.41%7.43M5.15%8.35M25.81%34.89M41.17%10.52M12.90%8.13M33.46%8.29M15.76%7.94M
Operating profit 9.91%-59.91M27.00%-13.5M3.25%-14.32M15.37%-14.78M-9.95%-17.31M-19.82%-66.51M-22.17%-18.5M-7.06%-14.8M-28.63%-17.46M-21.44%-15.74M
Net non-operating interest income expense -11.95%-8.7M-6.35%-2.65M-26.01%-2.62M-8.63%-1.83M-5.53%-1.6M-48.20%-7.77M-100.32%-2.49M-24.55%-2.08M-29.11%-1.68M-47.81%-1.52M
Non-operating interest expense 11.95%8.7M6.35%2.65M26.01%2.62M8.63%1.83M5.53%1.6M48.20%7.77M100.32%2.49M24.55%2.08M29.11%1.68M47.81%1.52M
Other net income (expense) 183.24%7.91M334.95%17M-296.63%-9.89M-3.84%1.23M59.05%-430K-413.68%-9.5M-400.62%-7.24M68.94%-2.49M196.06%1.28M-131.45%-1.05M
Gain on sale of security 432.44%30.4M1,204.30%21.3M-198.75%-4.27M218.23%6.76M460.31%6.88M57.23%5.71M-145.50%-1.93M169.13%4.33M164.05%2.12M-74.43%1.23M
Special income (charges) -20.87%-17.4M64.46%-1.6M41.29%-4M-394.09%-4.52M-235.42%-7.28M-166.39%-14.39M-155.73%-4.49M-285.75%-6.82M-93.64%-914K-54.19%-2.17M
-Less:Other special charges 20.87%17.4M-64.46%1.6M-41.29%4M394.09%4.52M235.42%7.28M166.39%14.39M155.73%4.49M285.75%6.82M93.64%914K54.19%2.17M
Other non- operating income (expenses) -521.49%-5.09M---2.71M---1.61M-1,611.94%-1.01M78.30%-23K-950.00%-819K---------32.32%67K-103.85%-106K
Income before tax 27.55%-60.7M103.02%851K-38.48%-26.83M13.94%-15.38M-5.63%-19.34M-33.83%-83.78M-101.92%-28.22M17.63%-19.37M-23.68%-17.87M-71.91%-18.31M
Income tax -537K0
Net income 28.19%-60.16M104.92%1.39M-38.48%-26.83M13.94%-15.38M-5.63%-19.34M-33.83%-83.78M-101.92%-28.22M17.63%-19.37M-23.68%-17.87M-71.91%-18.31M
Net income continuous Operations 28.19%-60.16M104.92%1.39M-38.48%-26.83M13.94%-15.38M-5.63%-19.34M-33.83%-83.78M-101.92%-28.22M17.63%-19.37M-23.68%-17.87M-71.91%-18.31M
Minority interest income
Net income attributable to the parent company 28.19%-60.16M104.92%1.39M-38.48%-26.83M13.94%-15.38M-5.63%-19.34M-33.83%-83.78M-101.92%-28.22M17.63%-19.37M-23.68%-17.87M-71.91%-18.31M
Preferred stock dividends
Other preferred stock dividends -7.00%1.32M-49.82%137K167.42%353K26.98%560K-53.35%265K-20.29%1.41M-19.94%273K-74.57%132K-15.03%441K43.80%568K
Net income attributable to common stockholders 27.84%-61.48M104.39%1.25M-39.35%-27.18M12.95%-15.94M-3.86%-19.61M-32.34%-85.19M-99.02%-28.5M18.86%-19.51M-22.34%-18.31M-70.91%-18.88M
Basic earnings per share 42.86%-0.0400.00%-0.0250.00%-0.0150.00%-0.01-16.67%-0.07-100.00%-0.020.00%-0.02-100.00%-0.02-100.00%-0.02
Diluted earnings per share 42.86%-0.0400.00%-0.0250.00%-0.0150.00%-0.01-16.67%-0.07-100.00%-0.020.00%-0.02-100.00%-0.02-100.00%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -